BETHLEHEM, Pa., Oct. 11, 2017 -- B. Braun Medical Inc. will present its chronic care products at the Symposium on Advanced Wound Care Fall 2017 (SAWC) in Las Vegas, Nevada, from October 20 to 22. Attendees can visit booth #208 to learn about the Prontosan® line of wound healing products and the Flexima® 3S line of ostomy products, including:
- Prontosan Gel-X, the wound gel with betaine and polyhexanide to resist microbial colonization within a dressing and offer a gentle healing experience1
- Flexima 3S 2-Piece System ostomy product, with a guiding system designed for security
- Roll’Up Drainable Ostomy Pouches, with an integrated soft roll-up outlet
- B. Braun High Output System, including the High Output Pouch and Flow Collector with a 2-liter collection bag and kink-resistant, cuttable 5-foot-long white tubing
- Urostomy Pouches, featuring an open/closed tap with tactile open/close tap outlet
“With B. Braun Melsungen’s more than 40 years of experience with ostomy products and an extensive line of wound care products, B. Braun Medical will continue to extend its unique product solutions to patients and clinicians in the North American market,” said Jeff Straton, Vice President of New Business Development for B. Braun.
At SAWC, B. Braun will preview its myostoSM program for those living with an ostomy. For patients pre-surgery to many years post-ostomy, the soon-to-be-launched myosto program will include an online website resource and toll-free contact numbers that will offer general information about living with a stoma and measure patient satisfaction with B. Braun ostomy products.
For more information, visit www.BBraunUSA.com.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
1 Bradbury s., Fletcher J. Prontosan Made Easy. Wounds Int. 2011.2(2), 1-6.
Contact:
Jason Ford
B. Braun Medical Inc.
610.997.4722
[email protected]


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Washington Post Publisher Will Lewis Steps Down After Layoffs
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



